| |
Top 10 Reasons to Metamucil
-
You love your heart, and so do we.
The fiber in Metamucil® is proven to lower cholesterol.* Clinical studies have shown that, taken daily, 7 grams of soluble fiber from psyllium husk, the amount in three to four servings of Metamucil, may help reduce heart disease risk by lowering cholesterol.
Because you want to stay fit and trim, naturally.
Most Metamucil Powders and Capsules have a low glycemic index. Plus, if you're on a low-carb diet, you'll love the fact that Metamucil Capsules contain zero net carbs and 100 percent natural fiber.
An easy way to add fiber to your diet.
At 3 grams of dietary fiber per serving, taken up to three times per day, you can easily add as much as 9 grams of dietary fiber to your diet with Metamucil.
It helps your digestive health.
Metamucil helps relieve occasional constipation.
Healthy fiber + strong bones.
Metamucil Capsules Plus Calcium provide not only the fiber of Metamucil, but also as much calcium as an 8-ounce glass of milk (nondairy source) for strong bones.
Because your doctor says so.
Metamucil is the number-one doctor- and pharmacist-recommended fiber brand.
Adding fiber to your diet has never been tastier.
Metamucil Pink Lemonade flavor is a new, delicious way to help lower your cholesterol.* Mix Metamucil into at least 8 ounces of water for a delicious, convenient way to add 100% psyllium fiber to your diet.
Metamucil is more affordable than competitive brands.
Metamucil offers the widest range of products at the most affordable price.**
For your favorite dishes, it's your healthy secret ingredient.
Fibersure™, from the makers of Metamucil, is a clear-mixing fiber supplement that easily mixes into foods and drinks without changing taste or texture.
Because it's a healthy choice when you're on the go.
Metamucil Wafers provide a great-tasting way to increase your daily fiber intake. Each adult serving of Metamucil Wafers provides 6 grams of 100 percent natural fiber.
* As part of a diet low in saturated fat and cholesterol
** Cost per year of treatment as reported by the ACNielsen FD+ data, 12 months ending September 22, 2007.
|
|